Dietary Supplement
Isolated soy protein
Isolated soy protein is a dietary supplement with 3 clinical trials. Historical success rate of 50.0%.
Total Trials
3
Max Phase
—
Type
DIETARY SUPPLEMENT
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 1 completed trials
Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(33%)
Phase Distribution
Ph phase_2
1
33%
Ph not_applicable
1
33%
Ph phase_4
1
33%
Phase Distribution
0
Early Stage
1
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
1(33.3%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Terminated(1)
Other(1)
Detailed Status
Terminated1
unknown1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
50.0%
Most Advanced
Phase 4
Trials by Phase
Phase 21 (33.3%)
Phase 41 (33.3%)
N/A1 (33.3%)
Trials by Status
terminated133%
unknown133%
completed133%
Recent Activity
0 active trials
Showing 3 of 3
unknownnot_applicable
Efficacy and Safety of Protein Product in Volunteers With Sarcopenia
NCT05869305
terminatedphase_2
The Effect of Soy Protein on Post- Breast Cancer Surgery Pain
NCT01047774
completedphase_4
Cholesterol Lowering Treatment With Psyllium Husks and Isolated Soy Protein in Hypercholesterolemia
NCT01251991
Clinical Trials (3)
Showing 3 of 3 trials
NCT05869305Not Applicable
Efficacy and Safety of Protein Product in Volunteers With Sarcopenia
NCT01047774Phase 2
The Effect of Soy Protein on Post- Breast Cancer Surgery Pain
NCT01251991Phase 4
Cholesterol Lowering Treatment With Psyllium Husks and Isolated Soy Protein in Hypercholesterolemia
All 3 trials loaded
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 3